Clinical pharmacokinetics of tyrosine kinase inhibitorsNielka P. van Erp, Henk‐Jan Guchelaar, Hans Gelderblom|Cancer Treatment Reviews|2009Cited by 498
Elacridar improves sunitinib efficacy in colorectal cancer modelsDennis Poel, Nielka P. van Erp|European Journal of Pharmaceutical Sciences|2025Cited by 1